Sub Banner Image

Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets

Market Impact

Vandana Singh

·

September 10, 2025

·

Benzinga

ICER finds semaglutide and tirzepatide cost-effective for obesity but flags major affordability concerns and limited patient access at current prices.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.